Afzeta 30mg Tablet
By Afzeta
Rx
30 Tablet in a Bottle

Composition
Afatinib dimaleate(30mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
July, 2025

liver
Afzeta 30mg Tablet is considered safe for patients with liver disease based on the available information. The data indicates that adjusting the dosage of Afzeta 30mg Tablet may not be necessary for individuals with liver conditions. It is recommended to consult your doctor for personalized advice regarding the use of Afzeta 30mg Tablet in relation to liver health.

kidney
Afzeta 30mg Tablet is likely safe for patients with kidney disease, and dose adjustment may not be necessary. It is advisable to consult your doctor regarding the use of this medication.

alcohol
When taking Afzeta 30mg Tablet, it is safe to consume alcohol as it does not result in any negative side effects.

driving
It is not clear if Afzeta 30mg Tablet affects driving. Avoid driving if you have symptoms that impact focus and reaction time while using this medication.

pregnancy
During pregnancy, it is not safe to use Afzeta 30mg Tablet because there is clear evidence of harm to the baby. However, in rare life-threatening cases, a doctor may prescribe it if the benefits outweigh the risks. Always consult your doctor before taking this medication during pregnancy.

breastfeeding
Afzeta 30mg Tablet is likely unsafe during breastfeeding. Limited data indicates the drug may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Quinazoline and Butenamide Derivative |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹4433
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024